130 related articles for article (PubMed ID: 5079616)
1. [Experiences with Glibornurid, a new sulfonylurea derivative for the treatment of diabetes in adults].
Rosenstiel K
Med Welt; 1972 Sep; 23(36):1214-6. PubMed ID: 5079616
[No Abstract] [Full Text] [Related]
2. [Therapy of diabetes in adults using Glibornurid. Results and clinical studies].
Schöffling K; Mehnert H; Ewald W; Haupt E; Wicklmayr M; Beyer J; Nemeth N
Dtsch Med Wochenschr; 1973 May; 98(18):915-9. PubMed ID: 4633717
[No Abstract] [Full Text] [Related]
3. [Glibornurid in treatment of diabetes mellitus].
Rojszykowa E; Wrzesimski W
Pol Tyg Lek; 1974 Jan; 29(2):63-6. PubMed ID: 4820789
[No Abstract] [Full Text] [Related]
4. [Three-year experience with the antidiabetic glibornurid (Glutril)].
Hammerl H; Henk W; Köhn H; Kränzl C; Pichler O; Studlar M
Wien Med Wochenschr; 1974 Jul; 124(27):448-52. PubMed ID: 4210108
[No Abstract] [Full Text] [Related]
5. Long term treatment of diabetes mellitus with glibornuride. A new hypoglycemic agent.
Nava M; Quibrera R; Pérez Arocha N
Rev Invest Clin; 1973; 25(2):169-74. PubMed ID: 4198609
[No Abstract] [Full Text] [Related]
6. [Clinical evaluation of a new sulfonylurea (Ro-6-4563) in the treatment of stable diabetes in adults].
Artega A; Soto S; Eyzaguirre J; Foradori A; Alliende ME
Rev Med Chil; 1972 Jun; 100(6):635-8. PubMed ID: 5083349
[No Abstract] [Full Text] [Related]
7. [Glibornurid (Glutril, Roche)].
Worm J
Ugeskr Laeger; 1974 Dec; 136(49):2763-4. PubMed ID: 4446104
[No Abstract] [Full Text] [Related]
8. [Results of a clinical test on the oral antidiabetic agent glibornuride (Ro 6-4563)].
Leubner H
Wien Med Wochenschr; 1973 Apr; 123(17):277-82. PubMed ID: 4574026
[No Abstract] [Full Text] [Related]
9. [Clinical experiences in long-term therapy of adult diabetes using glibornuride (Ro 6-4563)].
Ewald W; Hartmann HM; Haupt E; Kunkel W; Neubauer M; Bartelt KM; Beyer J; Cordes U; Schulz F; Schöffling K
Med Klin; 1973 Mar; 68(12):376-85. PubMed ID: 4806346
[No Abstract] [Full Text] [Related]
10. A clinical trial of glibornuride in maturity-onset diabetes mellitus.
Tandhanand S; Vannasaeng S; Aswapokee N; Soongsavang V; Aphonsuvan S
J Med Assoc Thai; 1974 May; 57(5):232-6. PubMed ID: 4832761
[No Abstract] [Full Text] [Related]
11. [Clinical study of a new sulfonylurea antidiabetic, glibornuride].
Vernet A; Fabre J; Zahnd G
Schweiz Rundsch Med Prax; 1972 Dec; 61(52):1599-607. PubMed ID: 4630563
[No Abstract] [Full Text] [Related]
12. [Treatment of diabetes mellitus with glibornurid].
Vignati E; Liuzzi A; Chiodini PG
Minerva Med; 1973 Oct; 64(75):3900-6. PubMed ID: 4767761
[No Abstract] [Full Text] [Related]
13. [Glipizide, a new sulfonylurea in the treatment of diabetes mellitus].
Villaseñor A
Prensa Med Mex; 1973; 38(5):211-4. PubMed ID: 4782089
[No Abstract] [Full Text] [Related]
14. [First experiences with the sulfonylurea derivative glibornuride in diabetes therapy].
Wolfram G; Dörfler H; Zöllner N
Verh Dtsch Ges Inn Med; 1971; 77():552-4. PubMed ID: 5005531
[No Abstract] [Full Text] [Related]
15. [Clinical study with glypentide, new sulfonylurea hypoglycemic agent].
Pou Torelló JM; Vilaclara JM
Rev Iber Endocrinol; 1974; 21(125):427-30, 433-8, 441-2 passim. PubMed ID: 4608666
[No Abstract] [Full Text] [Related]
16. [Clinical evaluation of glypidizine, a new oral hypoglycemic agent].
Domingo Gutiérrez AJ; Fernández-Cruz A
Rev Iber Endocrinol; 1973; 20(117):289-303. PubMed ID: 4581992
[No Abstract] [Full Text] [Related]
17. [Treatment of diabetes with low doses of glypizide].
Lozano-Castañeda O; Schulte J; Gonzálex Barranco J; García Viveros M; Rull JA
Prensa Med Mex; 1974; 39(7-8):358-61. PubMed ID: 4453534
[No Abstract] [Full Text] [Related]
18. A new antidiabetic agent.
Gupta SD; Mukerjee AB
J Indian Med Assoc; 1974 Dec; 63(11):357-9. PubMed ID: 4282091
[No Abstract] [Full Text] [Related]
19. Clinical evaluation of glibornuride (glutril): a new oral antidiabetic drug.
van der Merwe M; van Rooyen R
S Afr Med J; 1973 Sep; 47(36):1638-42. PubMed ID: 4746966
[No Abstract] [Full Text] [Related]
20. [Clinical experiences with the new highly effective sulfonylurea derivative Ro 6-4563 (glibornuride) in long-term therapy of more than 100 aged diabetics].
Ewald W; Kunkel W; Schöffling K
Verh Dtsch Ges Inn Med; 1971; 77():554-6. PubMed ID: 5005532
[No Abstract] [Full Text] [Related]
[Next] [New Search]
